Patent ID: 11905274
Assignee: BEIJING TIDE PHARMACEUTICAL CO., LTD.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC C

Claim 9:
10. The compound according to claim 9, or a pharmaceutically acceptable salt, ester, stereoisomer, polymorph, solvate, N-oxide, isotopically labeled compound, or prodrug thereof, wherein:
R3 is 5- to 6-membered heteroaryl which is optionally selected from the group consisting of thienyl, furyl, pyrrolyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, isoxazolyl, isothiazolyl, oxadiazolyl, triazolyl, tetrazolyl, thiadiazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl and triazinyl; —C(═O)OR11; —C(═O)NR11S(═O)yNR11R12; —C(═O)NR11S(═O)yR12; or —S(═O)yNR11C(═O)OR12; and
wherein R11 and R12, at each occurrence, are each independently selected from the group consisting of H, C1-6 alkyl, C3-10 cyclic hydrocarbyl group, 3- to 10-membered heterocyclic group, C6-10 aryl, 5- to 14-membered heteroaryl and C6-12 aralkyl; and
y, at each occurrence, is each independently 2.